Background: Peripheral arterial disease (PAD) is commonly associated with coronary artery disease, and echocardiography is frequently performed before lower extremity revascularization (LER). However, the incidence of various echocardiographic findings in patients with PAD and their impact on the outcomes of LER has not been well studied. Reduced ejection fraction (EF) <= 40% is associated with increased major adverse limb events (MALE) after LER.Methods: The electronic medical records of patients undergoing LER in a single center were reviewed. Patients were divided based on the presence or absence of reduced EF. Patient, transthoracic echocardiogram, procedural characteristics, and outcomes were compared be-tween the 2 groups.Results: A total of 1,114 patients (N = 131, 11.8% with reduced EF) underwent LER between 2013 and 2019. Patients with reduced EF were more likely to be male and have a history of coronary artery disease and heart failure. Furthermore, they were more likely to have diastolic dysfunction with moderate to severe mitral and tricuspid valve regurgitation. Patients with reduced EF were more likely to undergo LER for chronic limb-threatening ischemia, and to be treated with endovascular procedures. Perioperatively, patients with reduced EF were more likely to develop myocardial infarction. Lastly, the 2 groups had no difference in overall MALE or major amputation. However, on KaplaneMeier curves, MALE-free survival was significantly lower for patients with reduced EF. Regression analysis demonstrated that indication and not EF was associated with MALE and MALE-free survival.Conclusions: Reduced EF is associated with decreased MALE-free survival for patients with PAD undergoing LER.
机构:
Univ Arkansas Med Sci, Coll Pharm, Div Pharmaceut Evaluat & Policy, 4301 W Markham St, Little Rock, AR 72205 USA
US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USAUniv Arkansas Med Sci, Coll Pharm, Div Pharmaceut Evaluat & Policy, 4301 W Markham St, Little Rock, AR 72205 USA
Gressler, Laura E. E.
Ramkumar, Niveditta
论文数: 0引用数: 0
h-index: 0
机构:
Geisel Sch Med, Hanover, NH USAUniv Arkansas Med Sci, Coll Pharm, Div Pharmaceut Evaluat & Policy, 4301 W Markham St, Little Rock, AR 72205 USA
Ramkumar, Niveditta
Marinac-Dabic, Danica
论文数: 0引用数: 0
h-index: 0
机构:
US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USAUniv Arkansas Med Sci, Coll Pharm, Div Pharmaceut Evaluat & Policy, 4301 W Markham St, Little Rock, AR 72205 USA
Marinac-Dabic, Danica
dosReis, Susan
论文数: 0引用数: 0
h-index: 0
机构:
Univ Maryland, Coll Pharm, Baltimore, MD USAUniv Arkansas Med Sci, Coll Pharm, Div Pharmaceut Evaluat & Policy, 4301 W Markham St, Little Rock, AR 72205 USA
dosReis, Susan
Goodney, Philip
论文数: 0引用数: 0
h-index: 0
机构:
Dartmouth Hitchcock Med Ctr, Sect Vasc Surg, Lebanon, NH USAUniv Arkansas Med Sci, Coll Pharm, Div Pharmaceut Evaluat & Policy, 4301 W Markham St, Little Rock, AR 72205 USA
Goodney, Philip
Mullins, C. Daniel
论文数: 0引用数: 0
h-index: 0
机构:Univ Arkansas Med Sci, Coll Pharm, Div Pharmaceut Evaluat & Policy, 4301 W Markham St, Little Rock, AR 72205 USA
Mullins, C. Daniel
Shaya, Fadia T. T.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Maryland, Coll Pharm, Baltimore, MD USAUniv Arkansas Med Sci, Coll Pharm, Div Pharmaceut Evaluat & Policy, 4301 W Markham St, Little Rock, AR 72205 USA